MENU
RPTX
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Repare Therapeutics (RPTX) Earnings Date & Reports

Repare Therapeutics Inc is a precision medicine oncology company focused on the development of synthetic lethality-based therapies for patients with cancer... Show more

A.I. Advisor
published Earnings

RPTX is expected to report earnings to fall 31.54% to -48 cents per share on November 05

Repare Therapeutics RPTX Stock Earnings Reports
Q3'25
Est.
$-0.49
Q1'25
Missed
by $0.08
Q4'24
Beat
by $0.14
Q3'24
Beat
by $0.06
Q2'24
Beat
by $0.05
The last earnings report on May 13 showed earnings per share of -70 cents, missing the estimate of -62 cents. With 103.54K shares outstanding, the current market capitalization sits at 65.19M.
View a ticker or compare two or three
RPTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
published price charts
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. RPTX showed earnings on May 13, 2025. You can read more about the earnings report here.
A.I. Advisor
published General Information

General Information

a company which engages in the research, development, and commercialization of precision oncology drugs targeting specific vulnerabilities of tumors in genetically defined patient populations

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
7210 Frederick-Banting Street
Phone
+1 857 412-7018
Employees
179
Web
https://www.reparerx.com